IMA-026

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

AsthmaHealthy

Phase 1

Study Evaluating IMA-026 in Healthy Subjects

CompletedNCT00517348

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-09-30End: 2008-07-31Target: 50Updated: 2009-06-25

Study Evaluating IMA-026 in Healthy Japanese Males

CompletedNCT00528099

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-10-31End: 2008-11-30Target: 50Updated: 2009-07-23

Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma

CompletedNCT00725582

Wyeth is now a wholly owned subsidiary of PfizerAsthma

Start: 2008-09-30End: 2009-06-30Target: 24Updated: 2009-06-02